Eli Lilly (NYSE: LLY) is a market darling, given its success in the GLP-1 weight-loss space. That's understandable, given the huge opportunity ahead in helping the world address a health issue that has such a material, and usually negative, impact on people's lives. But as you look at Eli Lilly,…